OWC Pharmaceutical Buy Hold or Sell Recommendation

OWCP -- USA Stock  

USD 0.0121  0.0001  0.83%

Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding OWC Pharmaceutical Research Corp is 'Strong Sell'. Macroaxis provides OWC Pharmaceutical buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding OWCP positions. The advice algorithm takes into account all of OWC Pharmaceutical available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from OWCP buy-and-hold prospective. Additionally take a look at OWC Pharmaceutical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Symbol
Execute Advice
Sell OWC PharmaceuticalBuy OWC Pharmaceutical
Strong Sell

Volatility

Hype Condition

Current Valuation

Odds of Distress

Analyst Consensus

Not Available
For the selected time horizon OWC Pharmaceutical Research Corp has a mean deviation of 6.8, semi deviation of 0.0, standard deviation of 10.91, variance of 119.09, downside variance of 0.0 and semi variance of 0.0
We provide buy or sell recommendation to complement the latest expert consensus on OWC Pharmaceutical Research Corp. Our dynamic recommendation engine exercises multi - dimensional algorithm to analyze the firm potential to grow using all technical and fundamental data available now. To make sure OWC Pharmaceutical is not overpriced, please check all OWC Pharmaceutical Research Corp fundamentals including its Price to Book, Current Ratio, Current Asset, as well as the relationship between Net Income and Beta . As OWC Pharmaceutical appears to be a penny stock we also advise to check out its Price to Book numbers.

OWC Pharmaceutical Trading Alerts and Improvement Suggestions

OWC Pharmaceutical generates negative expected return over the last 30 days
OWC Pharmaceutical has high historical volatility and very poor performance
OWC Pharmaceutical has some characteristics of a very speculative penny stock
The company reported previous year revenue of 50K. Net Loss for the year was (13.78M) with profit before overhead, payroll, taxes, and interest of 50K.
OWC PHARMACEUTICAL RESH CORP currently holds about 2.8M in cash with (2.79M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.

OWC Pharmaceutical Returns Distribution Density

Mean Return1.07Value At Risk12.23
Potential Upside14.96Standard Deviation10.91
 Return Density 
      Distribution 

OWC Pharmaceutical Greeks

α
Alpha over DOW
=1.39
β
Beta against DOW=2.06
σ
Overall volatility
=14.80
Ir
Information ratio =0.11

OWC Pharmaceutical Volatility Alert

OWC Pharmaceutical Research Corp is displaying above average volatility of 10.91 over selected time horizon. Investors should scrutinize OWC Pharmaceutical Research Corp independently to make sure intended market timing strategies are aligned with expectations about OWC Pharmaceutical volatility. OWC Pharmaceutical Research Corp is a penny stock. Although OWC Pharmaceutical may be in fact a good investment, many penny stocks are subject to artificial stock hype. Make sure you completely understand upside potential and downside risk of investing in OWC Pharmaceutical Research Corp. We encourage investors to look for the signals such us message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on this equity instrument if you perfectly time your entry and exit. However, remember that penny stocks that has been the subject of an artificial hype usually unable to maintain its increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The one and only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
    
 Better Than Average     
    
 Worse Than Average Compare OWC Pharmaceutical to competition

OWC Pharmaceutical Fundamental Vs Peers

FundamentalsOWC PharmaceuticalPeer Average
Return On Equity(0.0385)% (0.31)%
Return On Asset(114.58)% (0.14)%
Current Valuation3.36M16.62B
Shares Outstanding194.62M571.82M
Shares Owned by Insiders1.21% 10.09%
Shares Owned by Institutions0.01% 39.21%
Price to Earning(12.76)X28.72X
Price to Book57.33X9.51X
Price to Sales759.48X11.42X
Revenue50K9.43B
Gross Profit50K27.38B
EBITDA(3.37M)3.9B
Net Income(13.78M)570.98M
Cash and Equivalents2.8M2.7B
Cash per Share0.01X5.01X
Total Debt60K5.32B
Debt to Equity18.40% 48.70%
Current Ratio5.61X2.16X
Book Value Per Share(0.06)X1.93K
Cash Flow from Operations(2.79M)971.22M
Earnings Per Share(0.09)X3.12X
Number of Employees918.84K
Beta-5.99-0.15
Market Capitalization2.51M19.03B
Total Asset130K29.47B
Retained Earnings(4.24M)9.33B
Working Capital(75K)1.48B
Current Asset112K9.34B
Current Liabilities187K7.9B
Search macroaxis.com